Anzeige
Mehr »
Donnerstag, 23.10.2025 - Börsentäglich über 12.000 News
Das Comeback des Goldrauschs - diesmal ausgelöst durch eine Währungskrise
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
13:26Boehringer's Jascayd gains NMPA approval for idiopathic pulmonary fibrosis
MiPortal Therapeutics receives FDA orphan, fast track designations for PORT-77
DiCitius Oncology finalises McKesson deal for Lymphir distribution
FrTempus partners with Whitehawk on oncology research
16.10.FDA accepts Chiesi triple combination inhaler application for asthma
15.10.iQure, University of Padova collaborate to investigate iQ-007 mechanism
14.10.US FDA grants BeOne's sonrotoclax breakthrough designation for MCL
13.10.Adcendo receives FDA fast track status for ADCE-D01 to treat STS
10.10.Bio-Thera, Intas extend partnership for golimumab biosimilar
09.10.Nilo Therapeutics raises $101m to develop neural circuit therapies
08.10.AeroRx secures $21m for nebulised COPD treatment development
07.10.FDA accepts priority review for Orca Bio's hematological malignancy therapy
06.10.FDA fast-tracks Alto Neuroscience's ALTO-101 for CIAS treatment
01.10.FDA approves Novartis' Rhapsido for CSU treatment
30.09.BioLineRx partners with Hemispherian to advance brain cancer therapy
29.09.AbbVie files NDA with FDA for tavapadon to treat Parkinson's disease
26.09.Lilly secures EC approval for Kisunla to treat Alzheimer's disease
25.09.Sandoz launches generic iron sucrose injection in US market
24.09.Leqembi approved in Australia to treat early Alzheimer's
23.09.Avenzo Therapeutics secures $60m in series B funding for oncology therapies
22.09.J&J's Tremfya gets FDA approval for SC induction in active UC
19.09.Biogen to acquire Alcyone Therapeutics for $85m
18.09.Deciphera's Romvimza secures EC nod for TGCT treatment
17.09.Dualitas secures $65m for bispecific antibody pipeline
16.09.Argo Biopharma secures NMPA clearance for Phase II PNH trial